Home/Filings/4/0001493152-23-003230
4//SEC Filing

Breen Michael Martin 4

Accession 0001493152-23-003230

CIK 0000109657other

Filed

Jan 31, 7:00 PM ET

Accepted

Feb 1, 6:05 AM ET

Size

5.8 KB

Accession

0001493152-23-003230

Insider Transaction Report

Form 4
Period: 2023-01-27
Transactions
  • Award

    Option to purchase Common Stock

    2023-01-27+500,000500,000 total
    Exercise: $0.84Exp: 2033-01-26Common Stock (500,000 underlying)
Footnotes (1)
  • [F1]1/12th of the shares vest on the monthly anniversary of January 1, 2023 until fully vested, subject to full acceleration in the event the reporting person is not re-elected to the board of directors or is removed from the board of directors other than for misconduct, and the reporting person is involuntarily terminated by the registrant.

Documents

1 file

Issuer

GT Biopharma, Inc.

CIK 0000109657

Entity typeother

Related Parties

1
  • filerCIK 0001863633

Filing Metadata

Form type
4
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 6:05 AM ET
Size
5.8 KB